期刊文献+

肺癌组织中CD_(44v6)和nm23的表达及临床意义 被引量:1

EXPRESSION AND CLINICAL VALUE OF CD_(44V6) AND nm23 IN HUMAN CARCINOMA OF LUNG
原文传递
导出
摘要 目的 :探讨 CD4 4v6 和 nm 2 3在肺癌组织中的表达及意义。方法 :应用免疫组织化学方法 ,检测 5 1例肺癌组织中 CD4 4v6 和 nm2 3的表达情况 ,并分析其临床意义。结果 :在 5例类癌和 4例小细胞肺癌 (SCL C)中未见 CD4 4v6 表达。在非小细胞肺癌 (NSCL C)中 ,≤ 6 0岁和 >6 0岁组 CD4 4v6 的阳性率分别为 84 .0 %和 2 9.4 % ,两组间差异有非常显著性 (χ2 =12 .79;P<0 .0 1) ,低分化癌和高中分化癌中 CD4 4v6 的阳性率分别为 87.0 %和 31.6 % ,两组间差异有显著性 (χ2 =13.5 3,P<0 .0 1) ;有和无淋巴结转移组 CD4 4v6 的阳性率分别为 73.3%和 33.3% ,两组间差异有显著性 (χ2 =5 .82 ,P<0 .0 5 ) ;鳞癌和腺癌中 CD4 4v6 的阳性率分别为 85 .7%和 5 0 .0 % ,两组间差异有显著性 (χ2 =5 .0 5 ,P<0 .0 5 ) ;nm2 3在腺癌和鳞癌中的阳性率分别为 6 4 .3%和 14 .3% ,两组间差异有显著性 (χ2 =9.35 ,P<0 .0 1)。结论 :CD4 4v6 可反映 NSCL C的生物学特性 ,是预测其侵袭转移潜能和预后的指标。nm2 Objective:To study the expression and clinical value of CD 44v6 and nm23 in human carcinoma of lung.Methods:The expressions of CD 44v6 and nm23 in tissue samples of 51 carcinoma of lung were detected with the immunohistochemical stain method,and the results were related to clinical data.Results:There was no expression of CD 44v6 in all 5 cases of pulmanary carcinoids and 4 cases of SCLC.Positive rate of CD 44v6 expression in the group of ≤60 year and >60 year of NSCLC was 84.0% and 29.4%, respectively. There was a distinct statistical difference between the two groups(χ 2=12.79, P <0.01).Positive rate of CD 44v6 expression in undifferentiated tumor and in well differentiated ones was 87.0% and 31.6%, respectively.There was a distinct statistical difference between the two groups (χ 2=13.53, P <0.01). Positive rate of CD 44v6 expression in lymphnode positive group and in lymphnode negative one was 73.3% and 33.3% , respectively . There was a distinct statistical difference between the two groups ( χ 2=5.82 , P <0.05) . Positive rate of CD 44v6 expression in human squamous cell carcinoma of lung and adenocarcinoma of lung was 87.5% and 50.0% , respectively.There was a distinct statistical difference between the two groups (χ 2=5.05, P <0.05).Positive rate of nm23 expression in human adenocarcinoma and squamous cell carcinoma of lung was 64.3% and 14.3%,respectively.There was a distinct statistical difference between the two groups (χ 2=9.35, P <0.01).Conclusion:CD 44v6 might be marker in assessing biological behavior,invasion and metastatic potential and prognosis in human carcinoma of lung.It is necessary to cellect more samples for further study in order to confirm prognositc value of expression of nm23 in human carcinoma of lung.
机构地区 南通市肿瘤医院
出处 《肿瘤研究与临床》 CAS 2001年第6期404-406,共3页 Cancer Research and Clinic
关键词 肺癌 CD44V6 NM23 表达 Lung cancer CD 44v6 nm23
  • 相关文献

参考文献4

二级参考文献14

  • 1黄丹,廖剑辉,司徒锐.人肺癌细胞CD_(44)表达及其与淋巴结转移的相关性[J].中华病理学杂志,1997,26(2):116-117. 被引量:19
  • 2陈龙邦,江苏医学,1998年,增刊,293页
  • 3HautM,SteegPS,WillsonJK ,etal.Inductionofnm2 3geneex pressioninhumancolonicneoplasmsandequalexpressionincolontumorsofhighandlowmetastaticpotential[].JNatlCancerInst.1991
  • 4Montenarh M.Biochemical properties of the growth suppressor,oncoprotein p53[].Oncegene.1992
  • 5Steeg PS,Bevilacqua G,Kopper L,et al.Evidence for a novel gene associated with low tumor metastatic potential[].Journal of the National Cancer Institute.1988
  • 6HennessyC,HenryJA,MayFE,etal.Expressionofthean timetastaticgenenm2 3inhumanbreastcancer :anassociationwithgoodprognosis[].JNatlCancerInst.1991
  • 7Miuntain CF.Revisions in the international system for staging lung cancer[].Chest.1997
  • 8FlynnSD,MurrenJR,KirbyWM,etal.P glycoproteinexpres sionandmultidrugresistanceinadrenocorticalcarcinoma[].Journal of Surgery.1992
  • 9Yamaguchi A,Urano T,Goi T,et al.Expression of human nm23H1 and nm23-H2 proteins in hepatocellular carcinoma[].Cancer.1994
  • 10Ferguson AW,Flatow U,MacDonald NJ. et al.Increased sensitivity to cisplatin by nm23-transfected tumor cell lines[].Cancer Research.1996

共引文献23

同被引文献15

  • 1Folkman J, Klagsbrun M. Angiogenic factors. Sci, 1987, 235:442-447.Yam aguchi A,Urao T,Coi T,et al. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer,1994,73:33- 41.
  • 2Folkman J. What is the evidence that tumors are angiogenesis dependent. J Natl Cancer Inst, 1990, 82:4-6.
  • 3Aitkenhead M, Wang S, Nakatsu M, et al. Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, ig-h3, and Nr-CAM. Microvasc Res, 2002, 63: 159-171.
  • 4Pujol JL, Breton JL, Gervais R, et al. Phase ]II'doubleblind,placebo- controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy. Clin Oncol, 2007, 25:394-395.
  • 5Uthoff SM, Duohrow M, Schmldf MH, et al . VEGF isoforms and mutations in human colorestal cancer. Int J Cancer, 2002, 1010:32- 36.
  • 6Sheng H, Ace M, Dcihara H, et al. Prognostic value of vascular endothelial growth factor expression in primary lung carcinoma. Acta Med Okayama, 2000, 54:119-126.
  • 7Shimanuki Y, Takahashi K, Cui R, et al. Role of serum vascular endothelial growth factor in prediction of angiogenesis and prognosis for non-small cell lungcancer. Lung, 2005, 183:29-42.
  • 8Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor in associated with neovascularization and influences progression of non-smaU cell lung carcinoma . Clin Cancer Res,1997, 3:861-865.
  • 9Fakahashi T, Ueno H, Shibuya M. VEGF activates protein kinase C- dependent, but rasindependent raf-nek-map kinase pathway for DNA aynthsis in primary endothelial ceils. Oncogene, 1.999, 18:2221- 2230.
  • 10Steeg P S, Bevilacqua G, Kopper L. Evidence for a novel gene associated with low tumor metastatic potential. Natl Cancer Inst, 1988, 80:200- 204.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部